Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients
- DOI
- 10.3389/fphar.2026.1917835
- Published
- 11
- Container
- Frontiers in Pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1917835,
title = {Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients},
author = {Yamin Liu and Yamin Liu and Yunxiao Lin and Xueting Xing and Xueting Xing and Hai Zhang and Yongzhe Tang and Yongzhe Tang and Hao Wu and Shengying Qin and Ruizhuo Ouyang and Ruizhuo Ouyang and Cong Huai and Xiaoqing Zhang and Xiaoqing Zhang},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1917835},
url = {https://doi.org/10.3389/fphar.2026.1917835}
}RIS
TY - JOUR TI - Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients AU - Yamin Liu AU - Yamin Liu AU - Yunxiao Lin AU - Xueting Xing AU - Xueting Xing AU - Hai Zhang AU - Yongzhe Tang AU - Yongzhe Tang AU - Hao Wu AU - Shengying Qin AU - Ruizhuo Ouyang AU - Ruizhuo Ouyang AU - Cong Huai AU - Xiaoqing Zhang AU - Xiaoqing Zhang PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1917835 UR - https://doi.org/10.3389/fphar.2026.1917835 ER -
APA
Liu, Y., Liu, Y., Lin, Y., Xing, X., Xing, X., Zhang, H., Tang, Y., Tang, Y., Wu, H., Qin, S., Ouyang, R., Ouyang, R., Huai, C., Zhang, X., & Zhang, X. (2026). Whole-exome sequencing identifies genetic markers for taxane-induced multi-organ adverse effects in breast cancer patients. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1917835
Source records
- doaj · retrieved 2026-11-10T09:16:03.159Z